← Open Payments lookup

ELYSE SIPKA: Open Payments

NPI 1760154934 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$212 in 13 payments from 12 companies in 2025. Trend: 2023 $106 · 2024 $697 · 2025 $212

Food & beverage: $212
CompanyPaymentsAmount
Corium, LLC2$28
Otsuka America Pharmaceutical, Inc.1$21
Vanda Pharmaceuticals Inc.1$20
ABBVIE INC.1$19
Luye Pharma (USA) Ltd.1$18
Lundbeck LLC1$18
Teva Pharmaceuticals USA, Inc.1$16
Axsome Therapeutics, Inc.1$16
Orexo US, Inc.1$16
Indivior Inc.1$14

Products named: REXULTI, Azstarys, FANAPT, VRAYLAR, ERZOFRI EXTENDED-RELEASE, UZEDY, Auvelity, Zubsolv.

Industry payments across NY — which companies pay providers there.